Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
What AOD-9604 actually is AOD-9604, sometimes written as "GH fragment 176-191," is a synthetic peptide that reproduces the last sixteen amino acids of human growth hormone, specifically residues 176 through 191 of the C-terminus
Relax & Rehydrate: The treatment typically takes 30-60 minutes
The formula is: Dose Volume = Desired Dose divided by Concentration
Several GLP-1 agonists have FDA approval for other indications that may overlap with BED patient populations: Semaglutide (Wegovy) and liraglutide (Saxenda) are approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity Semaglutide (Ozempic), liraglutide (Victoza), dulaglutide (Trulicity), and tirzepatide (Mounjaro) are approved for type 2 diabetes management Tirzepatide (Zepbound) is approved for chronic weight management When clinicians prescribe GLP-1 agonists for BED, this constitutes off-label use a legal and common practice in medicine when evidence suggests potential benefit and approved treatments are inadequate
US$ 28.39
US$ 25.67
US$ 27.98
.png)
US$ 23.47
US$ 20.29
US$ 21.36
US$ 27.03
US$ 23.34
US$ 26.50
US$ 26.94
US$ 28.41
